Login / Signup

Combination therapy of KRAS G12V mRNA vaccine and pembrolizumab: clinical benefit in patients with advanced solid tumors.

Xinjing WangWei WangSiyi ZouZhiwei XuDan CaoShuai ZhangMinzhi WeiQian ZhanChenlei WenFanlu LiHao ChenDa FuLingxi JiangMing ZhaoBaiyong Shen
Published in: Cell research (2024)
Keyphrases
  • combination therapy
  • advanced non small cell lung cancer
  • binding protein
  • wild type
  • tyrosine kinase